Published in Ann Thorac Surg on February 01, 2003
Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis. Clin Lung Cancer (2011) 1.05
Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Eur Radiol (2012) 0.87
Rebuttal from Dr. Obiols and Dr. Call. Transl Lung Cancer Res (2016) 0.75
The role of endobronchial ultrasound versus mediastinoscopy for non-small cell lung cancer. J Thorac Dis (2017) 0.75
Cons: should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging? Transl Lung Cancer Res (2016) 0.75
Is routine preoperative mediastinoscopy indicated in clinical stage I non-small-cell lung cancer? Ann Thorac Surg (2004) 0.75
Lung cancer staging: an overview of the new staging system and implications for radiographic clinical staging. Semin Roentgenol (2011) 0.75
The Role of Fluorodeoxy-D-glucose Positron Emission Tomography/Computed Tomography in Nodal Staging of Nonsmall Cell Lung Cancer in Sequential Surgical Algorithm. World J Nucl Med (2017) 0.75
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res (2008) 9.29
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2015) 2.95
Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology (2007) 2.91
Effect of high-frequency chest wall oscillation on pulmonary function after pulmonary lobectomy for non-small cell lung cancer. Crit Care Med (2012) 2.69
Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest (2013) 2.52
Solitary fibrous tumors of the pleura: surgical outcome and clinical course. Ann Thorac Surg (2005) 2.46
Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res (2008) 2.31
A comparative analysis of video-assisted mediastinoscopy and conventional mediastinoscopy. Ann Thorac Surg (2011) 2.23
Prevalence of aortic intimal defect in surgically treated acute type A intramural hematoma. Ann Thorac Surg (2008) 2.19
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology (2005) 2.19
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis (2008) 2.17
Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol (2015) 2.17
The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol (2004) 1.99
Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med (2006) 1.72
Video-assisted thoracic surgery lobectomy: single institutional experience with 704 cases. Ann Thorac Surg (2010) 1.68
Descending necrotizing mediastinitis: a minimally invasive approach using video-assisted thoracoscopic surgery. Ann Thorac Surg (2004) 1.63
Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol (2009) 1.61
Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg (2013) 1.60
Mutational hotspots in the mitochondrial genome of lung cancer. Biochem Biophys Res Commun (2011) 1.54
Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med (2006) 1.54
Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer. J Clin Oncol (2004) 1.50
Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J Thorac Oncol (2009) 1.50
Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology (2003) 1.49
New TNM staging system for esophageal cancer: what chest radiologists need to know. Radiographics (2014) 1.49
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol (2010) 1.47
18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med (2006) 1.46
Dry pleural dissemination in non-small cell lung cancer: prognostic and diagnostic implications. Radiology (2011) 1.46
Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg (2013) 1.44
Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J Clin Oncol (2013) 1.40
Concurrent endobronchial carcinoid tumor and sarcoidosis. Intern Med (2010) 1.40
Pleural recurrence and long-term survival after thoracotomy and thoracoscopic lobectomy. Ann Thorac Surg (2013) 1.40
Pharyngo-colostomy with supraglottic partial laryngectomy in caustic oropharyngeal stricture. Ann Thorac Surg (2006) 1.39
Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res (2007) 1.38
Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer (2006) 1.36
Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol (2010) 1.35
Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol (2012) 1.34
Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer (2007) 1.32
Primary leiomyoma of the trachea, bronchus, and pulmonary parenchyma--a single-institutional experience. Eur J Cardiothorac Surg (2012) 1.32
Primary salivary gland-type lung cancer: surgical outcomes. Lung Cancer (2010) 1.32
Giant fibrovascular polyp of the hypopharynx: surgical treatment with the biappoach. J Korean Med Sci (2006) 1.32
Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res (2003) 1.29
Sixteen cases of sclerosing hemangioma of the lung including unusual presentations. J Korean Med Sci (2004) 1.27
The spectrum of benign esophageal lesions: imaging findings. Korean J Radiol (2002) 1.27
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget (2013) 1.27
High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histol Histopathol (2012) 1.26
Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res (2005) 1.25
Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology (2010) 1.24
Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol (2005) 1.23
Unplanned conversion to thoracotomy during video-assisted thoracic surgery lobectomy does not compromise the surgical outcome. World J Surg (2011) 1.22
Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer. Lung Cancer (2010) 1.21
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.21
Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis (2006) 1.20
Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest (2013) 1.19
Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing. Genes Chromosomes Cancer (2012) 1.19
Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol (2004) 1.18
The effect of postoperative change in bronchial angle on postoperative pulmonary function after upper lobectomy in lung cancer patients. Interact Cardiovasc Thorac Surg (2013) 1.17
Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res (2006) 1.16
Treatment of inflammatory myofibroblastic tumor of the chest: the extent of resection. Ann Thorac Surg (2007) 1.15
Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg (2010) 1.15
Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer. Eur J Nucl Med Mol Imaging (2013) 1.14
Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis (2004) 1.14